Kava medicine company to list on ASX
Fiji Kava will be the first kava listing on any global stock exchange.
Andrew Bevin
Fri, 05 Oct 2018
Hot Topic
NBR Focus: The Accountants 2024
Kava, a drink usually enjoyed by Pacific Islanders for its calming effects, could be the next big treatment for anxiety, stress, insomnia and muscle tension.
Australian medical company Fiji Kava will be conducting a $A13 million-dollar public offering this month, raising A$5.2 Million at 20c a
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Andrew Bevin
Fri, 05 Oct 2018
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Kava medicine company to list on ASX
Business,
76717